CIBC World Market’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Sell |
4,075
-373
| -8% | -$32.8K | ﹤0.01% | 1053 |
|
|
2025
Q1 | $405K | Buy |
4,448
+350
| +9% | +$31.9K | ﹤0.01% | 1009 |
|
|
2024
Q4 | $354K | Sell |
4,098
-19,007
| -82% | -$1.64M | ﹤0.01% | 1045 |
|
|
2024
Q3 | $2.2M | Buy |
23,105
+1,585
| +7% | +$151K | ﹤0.01% | 585 |
|
|
2024
Q2 | $1.97M | Buy |
21,520
+18,704
| +664% | +$1.71M | ﹤0.01% | 587 |
|
|
2024
Q1 | $255K | Buy |
2,816
+351
| +14% | +$31.8K | ﹤0.01% | 1083 |
|
|
2023
Q4 | $201K | Buy |
+2,465
| New | +$201K | ﹤0.01% | 1091 |
|
|
2023
Q1 | – | Sell |
-2,640
| Closed | -$205K | – | 1221 |
|
|
2022
Q4 | $205K | Buy |
+2,640
| New | +$205K | ﹤0.01% | 1058 |
|
|
2022
Q3 | – | Sell |
-3,212
| Closed | -$247K | – | 1207 |
|
|
2022
Q2 | $247K | Buy |
+3,212
| New | +$247K | ﹤0.01% | 1009 |
|